Hitomi Shiozaki
3 Papers
6 Citations
Hitomi Shiozaki is an academic researcher. The author has contributed to research in topics: Internal medicine & Adverse effect. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non–small-cell lung cancer
Tateaki Naito,Taro Okayama,Takashi Aoyama,Takuya Ohashi,Yoshiyuki Masuda,Madoka Kimura,Hitomi Shiozaki,Haruyasu Murakami,Hirotsugu Kenmotsu,Tetsuhiko Taira,Akira Ono,Kazushige Wakuda,Hisao Imai,Takuya Oyakawa,Takeshi Ishii,Shota Omori,Kazuhisa Nakashima,Masahiro Endo,Katsuhiro Omae,Keita Mori,Nobuyuki Yamamoto,Akira Tanuma,Toshiaki Takahashi +22 more
TL;DR: Skeletal muscle depletion accompanied with physical functional decline started in the early phase of the chemotherapy in elderly patients with advanced NSCLC, suggesting that there may be a need for early supportive care in these patients to prevent functional decline during chemotherapy.
65
Comparison of Nutrition-Related Adverse Events and Clinical Outcomes Between ICE (Ifosfamide, Carboplatin, and Etoposide) and MCEC (Ranimustine, Carboplatin, Etoposide, and Cyclophosphamide) Therapies as Pretreatment for Autologous Peripheral Blood Stem Cell Transplantation in Patients with Malignant Lymphoma.
Takashi Aoyama,Osamu Imataki,Hidekazu Arai,Tetsuo Kume,Hitomi Shiozaki,Naomi Katsumata,Mariko Mori,Keiko Ishide,Takashi Ikeda +8 more
TL;DR: Compared with MCEC therapy, ICE therapy improves nutrition-related adverse events and reduces hospital stay, conserving medical resources, with no significant improvement in long-term survival.
Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study.
Tateaki Naito,Taro Okayama,Takashi Aoyama,Takuya Ohashi,Yoshiyuki Masuda,Madoka Kimura,Hitomi Shiozaki,Haruyasu Murakami,Hirotsugu Kenmotsu,Tetsuhiko Taira,Akira Ono,Kazushige Wakuda,Hisao Imai,Takuya Oyakawa,Takeshi Ishii,Shota Omori,Kazuhisa Nakashima,Masahiro Endo,Katsuhiro Omae,Keita Mori,Nobuyuki Yamamoto,Akira Tanuma,Toshiaki Takahashi +22 more
TL;DR: Elderly NSCLC patients with cachexia showed higher risks for disability, prolonged hospitalizations, and higher inpatient medical costs while receiving chemotherapy than patients without cachexia, which might indicate that there is a potential need for an early intervention to minimize progression to or development of cachexia.